Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Rising legal costs stump pharma companies (in India)
Business Standard, India
Sunday, December 8, 2013 - 12:48pm
tags:
Indian
Granules India shareholders approve Auctus acquisition
Financial Express
Sunday, December 8, 2013 - 12:45pm
tags:
Granules India, Auctus Pharma, India
Pharma companies (in India) told to reveal quarterly drug data
Economic Times, India
Sunday, December 8, 2013 - 12:40pm
tags:
India
AbbVie leukemia drug impresses in early-stage trial
Reuters
Sunday, December 8, 2013 - 12:22pm
tags:
AbbVie, leukemia, ABT-199
J&J’s Drug Shows Promise for Rare Castleman Disease
Bloomberg
Sunday, December 8, 2013 - 12:20pm
tags:
JNJ, siltuximab, multicentric Castleman disease
ASH Conference: 3 Companies To Watch
Seeking Alpha
Sunday, December 8, 2013 - 12:15pm
tags:
Stemline Therapeutics, Portola, Acceleron
Cytokinetics Announces Presentation Providing Update on BENEFIT-ALS at International Symposium on ALS/MND
Yahoo/Reuters
Sunday, December 8, 2013 - 12:13pm
tags:
Cytokinetics, Tirasemtiv, amyotrophic lateral sclerosis
3 Lessons Big Pharma Learned From BioMarin in 2013
Motley Fool
Sunday, December 8, 2013 - 12:08pm
tags:
Biomarin
First Analysis of Extended Dosing with Celgene Epigenetic Agent CC-486 in Patients with Higher-Risk Myelodysplastic Syndromes Presented at ASH
Yahoo/BusinessWire
Sunday, December 8, 2013 - 12:07pm
tags:
CC-486, Celgene, myelodysplastic syndromes
Gilead Announces Interim Phase 2 Results for GS-9973 in Previously Treated Chronic Lymphocytic Leukemia
Yahoo/BusinessWire
Sunday, December 8, 2013 - 12:03pm
tags:
chronic lymphocytic leukemia, GS-9973, Gilead Sciences
Despite an Industry-Wide Decline, Some Pharmaceutical Companies Are Increasing Speaker Program Budgets
Pharmiweb
Saturday, December 7, 2013 - 1:22pm
tags:
drug marketing
Do Drugmaker Plans To Release Trial Data Go Far Enough?
Forbes
Saturday, December 7, 2013 - 1:17pm
tags:
3 Budding Drug Superstars in This Big Pharma's Future
Motley Fool
Saturday, December 7, 2013 - 1:12pm
tags:
Bristol-Myers Squibb
Johnson & Johnson Battles St. Jude for Cardiac Mapping Leadership
Motley Fool
Saturday, December 7, 2013 - 12:56pm
tags:
JNJ, St. Jude Medical, cardiac mapping
Increased Biotech Productivity and Innovation Reflected in FDA-Approved Drugs: One of the Top 10 Equity Analyst Interviews of 2013
Yahoo/Wall St Transcript
Saturday, December 7, 2013 - 12:54pm
tags:
High-Risk Pipeline Candidates and Limited Options Make Novartis an Iffy Buy Candidate
Motley Fool
Saturday, December 7, 2013 - 12:53pm
tags:
Novartis
Theravance, Glaxo COPD Drug Does Well In Asthma
investors.com
Saturday, December 7, 2013 - 12:52pm
tags:
Theravance
Arena Eyes Additional Opportunity With Belviq
Seeking Alpha
Saturday, December 7, 2013 - 12:50pm
tags:
Arena Pharmaceuticals, Belviq, smoking cessation, type 2 diabetes
HIV Returns in Two Men Thought Cured After Stem Cell Transplant
Bloomberg
Saturday, December 7, 2013 - 12:48pm
tags:
HIV, stem cells
Infinity Reports Preclinical Data at ASH Annual Meeting in Diffuse Large B-Cell Lymphoma and T-Cell Acute Lymphoblastic Leukemia Suggesting Broad Potential of IPI-145 in Blood Cancers
Yahoo/BusinessWire
Saturday, December 7, 2013 - 12:47pm
tags:
large B-cell lymphoma, lymphoma, leukemia, T-cell acute lymphoblastic leukemia, IPI-145, Infinity Pharmaceuticals

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.